NCT00383643
Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.
See it on ClinicalTrials.gov ↗48 people
66.7%
33.3%
32 womenmiddle line = equal numbers16 men
- Phase
- PHASE2
- Paid for by
- Stanford University
- Finished
- 2009-12
- Health conditions
- Sleep Initiation and Maintenance Disorders
- Who could join
- Anyone
- Ages
- 18 Years – 75 Years
- Average age
- mean 53.2 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Other 100%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Is a pregnant or lactating woman. (Any woman becoming pregnant during the study will be withdrawn from the study.)”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Is a pregnant or lactating woman. (Any woman becoming pregnant during the study will be withdrawn from the study.)”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Women must be surgically sterile, 2 years post-menopausal, or if of child-bearing potential, using a medically accepted method of birth control, and agree to continued use of this method for the duration of the study.”
- Only women past menopause
Women who could still get pregnant were turned away.
“Women must be surgically sterile, 2 years post-menopausal, or if of child-bearing potential, using a medically accepted method of birth control, and agree to continued use of this method for the duration of the study.”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Has any clinically significant, uncontrolled medical or psychiatric conditions. (treated or untreated)”
Study titles and rules are shown in their original English.